Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
2.290
-0.020 (-0.87%)
Nov 21, 2024, 4:00 PM EST - Market closed
Protara Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 47 | 21 | 30 | 76 | 271 | - | |
| Market Cap Growth | 99.54% | -29.43% | -60.18% | -72.06% | - | - | |
| Enterprise Value | -30 | -47 | -70 | -55 | 106 | - | |
| Last Close Price | 2.29 | 1.88 | 2.68 | 6.75 | 24.21 | - | |
| PB Ratio | 0.58 | 0.31 | 0.30 | 0.47 | 1.36 | - | |
| P/TBV Ratio | 0.46 | 0.31 | 0.30 | 0.57 | 1.60 | - | |
| Debt / Equity Ratio | 0.06 | 0.08 | 0.06 | 0.04 | 0.01 | - | |
| Quick Ratio | 9.43 | 10.70 | 14.78 | 21.37 | 57.84 | 0.17 | |
| Current Ratio | 9.85 | 11.17 | 15.01 | 21.66 | 58.13 | 0.23 | |
| Return on Equity (ROE) | -52.97% | -47.44% | -49.96% | -26.17% | -34.48% | -591.11% | |
| Return on Assets (ROA) | -31.42% | -28.36% | -16.42% | -15.80% | -21.07% | -143.64% | |
| Return on Capital (ROIC) | -33.90% | -29.91% | -16.90% | -16.07% | -21.72% | -369.45% | |
| Earnings Yield | -89.01% | -189.67% | -218.41% | -62.30% | -12.52% | - | |
| FCF Yield | -176.45% | -88.01% | -46.28% | -8.95% | - | |
| Buyback Yield / Dilution | -46.80% | -0.64% | -0.24% | -55.28% | -180.66% | 76.99% | |
| Total Shareholder Return | -46.80% | -0.64% | -0.24% | -55.28% | -180.66% | 76.99% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.